Skip to main content
Top
Published in: Sleep and Breathing 2/2013

01-05-2013 | Case Report

Obstructive sleep apnea caused by substernal goiter presenting as nonarteritic ischemic optic neuropathy

Authors: Allen J. Blaivas, Faisal Uddin

Published in: Sleep and Breathing | Issue 2/2013

Login to get access

Excerpt

Ischemic optic neuropathy is the most common optic nerve disorder in patients over age 50 [1] and may be categorized as arteritic and nonarteritic. Nonarteritic anterior ischemic optic neuropathy (NAION) involves a loss of vision due to optic nerve infarction from insufficient blood supply and is the most common variant of ischemic optic neuropathy. There are approximately 6,000 new cases annually [2]. Substernal goiter has also been shown to be a risk factor for positional dyspnea, tracheal compression, and obstructive sleep apnea. We present a case of NAION in a normal weight male with no significant craniofacial abnormalities who likely developed obstructive sleep apnea due to a large substernal goiter ultimately resulting in bilateral NAION. …
Literature
2.
go back to reference Hattenhauer MG, Leavitt JA, Hodge DO, Grill R, Gray DT (1997) Incidence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 123:103–107PubMed Hattenhauer MG, Leavitt JA, Hodge DO, Grill R, Gray DT (1997) Incidence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 123:103–107PubMed
3.
go back to reference Guo Q, Wang Y, Qing YL, Li M, Wan HY (2012) Levels of thioredoxin are related to the severity of obstructive sleep apnea: based on oxidative stress concept. Sleep Breath. doi:10.1007/s11325-012-0692-4 Guo Q, Wang Y, Qing YL, Li M, Wan HY (2012) Levels of thioredoxin are related to the severity of obstructive sleep apnea: based on oxidative stress concept. Sleep Breath. doi:10.​1007/​s11325-012-0692-4
4.
go back to reference Mojon DS, Hedges TR, Ehrenberg B, Karam EZ, Goldblum D, Abou-Chebl GM, Mathis J (2002) Association between sleep apnea syndrome and nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol 120(5):601–605PubMed Mojon DS, Hedges TR, Ehrenberg B, Karam EZ, Goldblum D, Abou-Chebl GM, Mathis J (2002) Association between sleep apnea syndrome and nonarteritic anterior ischemic optic neuropathy. Arch Ophthalmol 120(5):601–605PubMed
5.
go back to reference Palombi K, Renard E, Levy P, Chiquet C, Deschaux C, Romanet JP, Pépin JL (2006) Non-arteritic anterior ischaemic optic neuropathy is nearly systematically associated with obstructive sleep apnoea. Br J Ophthalmol 90(7):879–882PubMedCrossRef Palombi K, Renard E, Levy P, Chiquet C, Deschaux C, Romanet JP, Pépin JL (2006) Non-arteritic anterior ischaemic optic neuropathy is nearly systematically associated with obstructive sleep apnoea. Br J Ophthalmol 90(7):879–882PubMedCrossRef
6.
go back to reference Li J, McGwin G, Vaphiades MS, Owsley C (2007) Non-arteritic anterior ischaemic optic neuropathy and presumed sleep apnoea syndrome screened by the sleep apnea scale of the Sleep Disorders Questionnaire. Br J Ophthalmol 91(11):1524–1527PubMedCrossRef Li J, McGwin G, Vaphiades MS, Owsley C (2007) Non-arteritic anterior ischaemic optic neuropathy and presumed sleep apnoea syndrome screened by the sleep apnea scale of the Sleep Disorders Questionnaire. Br J Ophthalmol 91(11):1524–1527PubMedCrossRef
7.
go back to reference Haight JJ, Djupesland PG (2003) Nitric oxide and obstructive sleep apnea. Sleep Breath 7(2):53–61PubMedCrossRef Haight JJ, Djupesland PG (2003) Nitric oxide and obstructive sleep apnea. Sleep Breath 7(2):53–61PubMedCrossRef
8.
go back to reference Behbehani R, Mathews MK, Sergott RC, Savino PJ (2005) Nonarteritic anterior ischemic optic neuropathy in patients with sleep apnea while being treated with continuous positive airway pressure. Am J Ophthalmol 139(3):518–521PubMedCrossRef Behbehani R, Mathews MK, Sergott RC, Savino PJ (2005) Nonarteritic anterior ischemic optic neuropathy in patients with sleep apnea while being treated with continuous positive airway pressure. Am J Ophthalmol 139(3):518–521PubMedCrossRef
9.
go back to reference Dopp JM, Morgan BJ (2010) Pharmacologic approaches for the management of symptoms and cardiovascular consequences of obstructive sleep apnea in adults. Sleep Breath 14(4):307–315PubMedCrossRef Dopp JM, Morgan BJ (2010) Pharmacologic approaches for the management of symptoms and cardiovascular consequences of obstructive sleep apnea in adults. Sleep Breath 14(4):307–315PubMedCrossRef
10.
go back to reference Agrama MT (2011) Thyroidectomy for goiter relieves obstructive sleep apnea: results of 8 cases. Ear Nose Throat J 90(7):315–317PubMed Agrama MT (2011) Thyroidectomy for goiter relieves obstructive sleep apnea: results of 8 cases. Ear Nose Throat J 90(7):315–317PubMed
11.
go back to reference Stang MT, Armstrong MJ, Ogilivie JB, Yip L, McCoy KL, Faber CN, Carty SE (2012) Positional dyspnea and tracheal compression as indications for goiter resection. Arch Surg 147(7):621–626PubMedCrossRef Stang MT, Armstrong MJ, Ogilivie JB, Yip L, McCoy KL, Faber CN, Carty SE (2012) Positional dyspnea and tracheal compression as indications for goiter resection. Arch Surg 147(7):621–626PubMedCrossRef
Metadata
Title
Obstructive sleep apnea caused by substernal goiter presenting as nonarteritic ischemic optic neuropathy
Authors
Allen J. Blaivas
Faisal Uddin
Publication date
01-05-2013
Publisher
Springer-Verlag
Published in
Sleep and Breathing / Issue 2/2013
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-012-0758-3

Other articles of this Issue 2/2013

Sleep and Breathing 2/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine